EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

about

The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China.

P2860

Q37365512-6AFF4780-5823-4667-A3D2-6D38C2FE2932

P2860

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

Item

http://www.wikidata.org/entity/Q39651867

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

@en

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

@nl

type

Item

label

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

@en

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

@nl

prefLabel

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

@en

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

@nl

P1476

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

@en

P2093

Jie Chen

http://www.w3.org/2001/XMLSchema#string

Ke Zheng

http://www.w3.org/2001/XMLSchema#string

Lili Jiang

http://www.w3.org/2001/XMLSchema#string

Wei-Ping Liu

http://www.w3.org/2001/XMLSchema#string

Wei-Ya Wang

http://www.w3.org/2001/XMLSchema#string

Wen-Yan Zhang

http://www.w3.org/2001/XMLSchema#string

Xue-Ying Su

http://www.w3.org/2001/XMLSchema#string

Yan Zou

http://www.w3.org/2001/XMLSchema#string

Yuan Tang

http://www.w3.org/2001/XMLSchema#string

P2860

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Screening for epidermal growth factor receptor mutations in lung cancer

Efficacy analysis of tyrosine kinase inhibitors on rare non-small cell lung cancer patients harboring complex EGFR mutations

Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer.

EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey

Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors.

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.

P304

915-919

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737159.2016.1199961

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27348572

http://www.w3.org/2001/XMLSchema#string

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

about

P2860

P2860

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698